IntroMedic Co., Ltd.

KOSDAQ:A150840 Stock Report

Market Cap: ₩223.7b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

IntroMedic Past Earnings Performance

Past criteria checks 0/6

IntroMedic's earnings have been declining at an average annual rate of -19.3%, while the Medical Equipment industry saw earnings growing at 22.7% annually. Revenues have been declining at an average rate of 5.1% per year.

Key information

-19.3%

Earnings growth rate

0.7%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate-5.1%
Return on equity-31.4%
Net Margin-193.7%
Last Earnings Update31 Mar 2022

Recent past performance updates

Recent updates

IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

Mar 11
IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

IntroMedic (KOSDAQ:150840) Is Carrying A Fair Bit Of Debt

Jan 17
IntroMedic (KOSDAQ:150840) Is Carrying A Fair Bit Of Debt

What Type Of Returns Would IntroMedic's(KOSDAQ:150840) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Nov 24
What Type Of Returns Would IntroMedic's(KOSDAQ:150840) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Revenue & Expenses Breakdown

How IntroMedic makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A150840 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 228,012-15,52310,191305
31 Dec 217,871-13,7429,459764
30 Sep 218,203-5,5398,703901
30 Jun 217,730-4,0878,627723
31 Mar 217,005-5,2947,135731
31 Dec 205,963-7,2247,711350
30 Sep 207,090-19,86810,463297
30 Jun 207,174-21,24110,645516
31 Mar 208,080-18,96110,376725
31 Dec 198,836-18,93710,117873
30 Sep 199,084-4,8498,613961
30 Jun 1910,271-5,3078,4951,003
31 Mar 199,918-5,7638,5831,082
31 Dec 189,874-5,0657,8961,205
30 Sep 189,151-5,6438,0451,175
30 Jun 188,323-4,1256,8861,197
31 Mar 189,089-3,3406,4991,151
31 Dec 179,009-3,8856,5571,137
31 Mar 178,407-6,9397,1291,184
31 Dec 168,430-6,6777,1601,253
30 Sep 168,542-4,0016,6141,027
30 Jun 168,452-2,9556,6081,273
31 Mar 168,544-1,5745,7461,420
31 Dec 158,260-8745,4441,251
30 Sep 1510,3825856,5721,262
30 Jun 1510,9011,2435,9151,029

Quality Earnings: A150840 is currently unprofitable.

Growing Profit Margin: A150840 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A150840 is unprofitable, and losses have increased over the past 5 years at a rate of 19.3% per year.

Accelerating Growth: Unable to compare A150840's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A150840 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4%).


Return on Equity

High ROE: A150840 has a negative Return on Equity (-31.39%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/06/11 11:40
End of Day Share Price 2022/03/14 00:00
Earnings2022/03/31
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IntroMedic Co., Ltd. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jee Hyung HanKorea Investment & Securities Co., Ltd.